FIGURE 1 Analytic framework for systematic reviews on types and amounts of CFBs consumed and growth, size, and body ... FIGURE 1 Analytic framework for.

Slides:

Advertisements

Similar presentations

Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.

Advertisements

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

FIGURE 1 Distribution of total body iron (calculated from serum ferritin and soluble transferrin receptor ... FIGURE 1 Distribution of total body iron.

FIGURE 1 Association of habitual coffee intake with incident of CVD in the UK Biobank and in an earlier meta-analysis ... FIGURE 1 Association of habitual.

Figure 1 Data-selection process

Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Mechanism of mortality benefit associated with radial access

Figure 1 Number of percutaneous coronary interventions (PCI) in mainland China, 2017 (total 753 142). Data from China ... Figure 1 Number of percutaneous.

FIGURE 1 Percentage of patients with sarcopenia or low SMD across the spectrum of total adiposity (N = 3262). SMD, ... FIGURE 1 Percentage of patients.

FIGURE 1 PRISMA flow diagram of studies in systematic review

Fig. 1. Relative potency ratios of 13 active ingredients used against a fall armyworm population collected in Puerto ... Fig. 1. Relative potency ratios.

FIGURE 1 Patient enrolment flowchart. SBS, short bowel syndrome.

Figure 1 Phases of the research. Author’s own work.

FIGURE 1 Flowchart of the study population.

FIGURE 3 Incidence of anemia by WDDS category at baseline and endpoint

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1 Mean (±SE) egg investment in female zebra finches shortly after a second injection with either tetanus toxoid ... Figure 1 Mean (±SE) egg investment.

AHA: American Heart Association; ALT: ...

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.

Source: Figure created by the author based on data ...

bDMARD: biologic DMARD.

Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.

RCTs: randomized controlled ...

Fig. 1 MRI aspect of an osteitis of the left acetabulum at baseline (A), 3 months (B), 1 year (C) and 2 years later, ... Fig. 1 MRI aspect of an osteitis.

Figure 1. Historical dialectic framework to assess transnational advocacy network influence Unless provided in the caption above, the following copyright.

Take home figure The protective role of CNP/NPR-B/NPRC.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Fig. 1 Subacute cutaneous lupus erythematous at the lower limbs

Fig. 1 Flow chart of included patients for analyses

Fig. 1 Flow chart for selection of study subjects

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Figure 1 Relationships between pair indices of dance performance (joint entropy or mutual information) and the past ... Figure 1 Relationships between.

FIGURE 1 Flow chart showing the number of individuals at each stage of the experiment. Among the 61 dyads who ... FIGURE 1 Flow chart showing the number.

FIGURE 1 Ten-year trends in growth by diet group (human milk only, combination of human milk with formula or ... FIGURE 1 Ten-year trends in growth by.

FIGURE 1 Consolidated Standards of Reporting Trials (CONSORT) diagram for the follow-up study. Unless provided in the caption above, the following copyright.

FIGURE 1 WIC exposure groups included in the study

Figure 1. Results of search based on the PRISMA statement.14

Figure 1. Percentage of Pacific and European children completing all components of B4SC in 2013 and 2015 Figure 1. Percentage of Pacific and European.

Figure 1. Trunk and leg fat over study period. LS, log transformed.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Fig. 1 Kaplan-Meier plot presenting no difference in progression to RA in patients with clinically suspect ... Fig. 1 Kaplan-Meier plot presenting no difference.

Figure 1. Oncoprint of selected pathogenic alterations detected in ctDNA. Unless provided in the caption above, the following copyright applies to the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

FIGURE 1 Major activities in the working week of a banker

FIGURE 2 Stable isotope infusion protocol

FIGURE 1 Weight loss for participants (n = 128) who consumed the high-egg (n = 66) or the low-egg (n = 62) diets ... FIGURE 1 Weight loss for participants.

FIGURE 1 Study population. EVD, Ebola virus disease.

Fig. 1 A network representation of top 100 co-occurring terms

FIGURE 2 Regression of age- and sex-adjusted mean BMI (A) and WC (B) across obesity (BMI) GRSs. Black dots: age- and ... FIGURE 2 Regression of age- and.

Fig. 1 Statistics of the main characters’ dialogues.

Figure 1 Patient selection.

Figure 1 Grant agencies and charitable foundations supporting Plan S.

Figure 1. Prevalence of parasitic infection and anemia among the children. Unless provided in the caption above, the following copyright applies to the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Figure 3. Key words and phrases from narrative text by classification category. Unless provided in the caption above, the following copyright applies to.

Fig. 1: World distribution of field sampling locations of Aedes aegypti and Aedes mascarensis screened for Wolbachia ... Fig. 1: World distribution of.

Figure 1. PRISMA flow diagram summarizing pathway of included studies

FIGURE 1 Results for primary meta-analysis of controlled trials for the effects of walnut-enriched compared with ... FIGURE 1 Results for primary meta-analysis.

Figure 1 Strategies for reconciling protection and participation.

Figure 1. Kaplan Meier curves showing crude product limit survival estimates and 95% confidence intervals for time to ... Figure 1. Kaplan Meier curves.

Figure 1. Measuring respondent unhappiness with their child marrying someone from the other party and happiness with ... Figure 1. Measuring respondent.

Figure 1 ABCDE of primary prevention.2

Figure 1. Forest plot of lung cancer mortality in LDCT trials.

Figure 1. Evolutionary process of a policy field.

Table 2. Mean noise level results for hand dryers in dBA

Figure 1. Overall response rates in wild-type versus RAS and RAS/BRAF mutations detected by nanofluidic digital PCR ... Figure 1. Overall response rates.

Figure 1. Estimated weight functions (dotted-dashed lines) and pointwise 95% bootstrap confidence intervals (shaded ... Figure 1. Estimated weight functions.

Presentation transcript:

FIGURE 1 Analytic framework for systematic reviews on types and amounts of CFBs consumed and growth, size, and body ... FIGURE 1 Analytic framework for systematic reviews on types and amounts of CFBs consumed and growth, size, and body composition. This framework shows the overall scope of the project, including the population, the interventions and/or exposures, comparators, and outcomes of interest. It also includes definitions of key terms and identifies key confounders considered in the systematic review on types and amounts of CFBs consumed and growth, size, and body composition. The independent variable/exposure of interest included types and/or amounts of CFBs, which encompassed dietary patterns during the complementary feeding period and the introduction of specific CFBs. The outcomes of interest included weight, height/length, body circumferences, and/or proxies for body composition such as fat mass or fat mass index, weight-to-height ratios including BMI, and terms for weight status such as incidence, prevalence, frequency, or risk of malnutrition, healthy weight, overweight, or obesity. CFB, complementary food and beverage. Unless provided in the caption above, the following copyright applies to the content of this slide: © American Society for Nutrition 2019.This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) Am J Clin Nutr, Volume 109, Issue Supplement_7, 28 March 2019, Pages 956S–977S, https://doi.org/10.1093/ajcn/nqy281 The content of this slide may be subject to copyright: please see the slide notes for details.